Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

Posted: April 3, 2025 at 2:45 am

WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the appointment of Gavin Corcoran, M.D. to its Board of Directors.

Read the rest here:
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

Related Posts